Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses improvements in lung function observed in patients enrolled in the BOREAS trial. The results of the BOREAS ...

High levels of phenotypic age acceleration (PhenoAgeAccel) were found to have a more significant effect on lung function in patients with chronic obstructive pulmonary disease (COPD), older patients, ...

Blood test tubes with multi-colored lids standing on medical documents. Do serum sclerostin levels play a role in COPD? Researchers analyzed relationships between blood SOST and body composition, bone ...

"In patients with risk factors for COPD and respiratory symptoms, referring for spirometry is important to triage who will and won’t benefit from bronchodilators." – Meilan Han, MD, Professor of ...

This study, published in the journal Nature Communications, determined the mechanism of this live biotherapeutic product — a powder mixture of living Lactobacilli bacteria — to reduce neutrophilic ...

“Patients with pulmonary edema generally describe breathlessness. Sometimes they feel like they are suffocating or breathing ...

Further tiotropium + olodaterol FDC data on patient outcomes such as quality of life are due to report later this year SAN DIEGO--(BUSINESS WIRE)--For media outside of the US, the UK & Canada only ...

Please provide your email address to receive an email when new articles are posted on . A smartphone-based tool that employs acoustic sensing and machine learning techniques is set to undergo testing.

WASHINGTON -- Treatment with the first-in-class dual phosphodiesterase 3/4 inhibitor ensifentrine reduced exacerbation rates and improved other key outcomes in patients with chronic obstructive ...